Robert C Murphy1, Akira Kawashima, Patrick J Peller. 1. Department of Radiology, Division of Nuclear Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA. murphy.robert@mayo.edu
Abstract
OBJECTIVE: The objective of this article is to provide an illustrative tutorial showing the utility of (11)C-choline PET/CT for imaging prostate cancer. CONCLUSION: Carbon-11-labeled choline PET/CT is a powerful adjunct to the currently available imaging modalities for evaluating prostate cancer. As with any diagnostic method, false-positives and false-negatives occur. However, these diagnostic errors can be reduced if readers are familiar with the normal and abnormal patterns of (11)C-choline distribution in the body.
OBJECTIVE: The objective of this article is to provide an illustrative tutorial showing the utility of (11)C-choline PET/CT for imaging prostate cancer. CONCLUSION:Carbon-11-labeled choline PET/CT is a powerful adjunct to the currently available imaging modalities for evaluating prostate cancer. As with any diagnostic method, false-positives and false-negatives occur. However, these diagnostic errors can be reduced if readers are familiar with the normal and abnormal patterns of (11)C-choline distribution in the body.
Authors: Michael Souvatzoglou; Matthias Eiber; Toshiki Takei; Sebastian Fürst; Tobias Maurer; Florian Gaertner; Hans Geinitz; Alexander Drzezga; Sibylle Ziegler; Stephan G Nekolla; Ernst J Rummeny; Markus Schwaiger; Ambros J Beer Journal: Eur J Nucl Med Mol Imaging Date: 2013-07-02 Impact factor: 9.236
Authors: A E Ross; F Y Feng; M Ghadessi; N Erho; A Crisan; C Buerki; D Sundi; A P Mitra; I A Vergara; D J S Thompson; T J Triche; E Davicioni; E J Bergstralh; R B Jenkins; R J Karnes; E M Schaeffer Journal: Prostate Cancer Prostatic Dis Date: 2013-10-22 Impact factor: 5.554
Authors: Ilaria Grassi; Cristina Nanni; Vincenzo Allegri; Joshua James Morigi; Gian Carlo Montini; Paolo Castellucci; Stefano Fanti Journal: Am J Nucl Med Mol Imaging Date: 2011-12-15